These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17125246)

  • 1. Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.
    Potin D; Launay M; Monatlik F; Malabre P; Fabreguettes M; Fouquet A; Maillet M; Nicolai E; Dorgeret L; Chevallier F; Besse D; Dufort M; Caussade F; Ahmad SZ; Stetsko DK; Skala S; Davis PM; Balimane P; Patel K; Yang Z; Marathe P; Postelneck J; Townsend RM; Goldfarb V; Sheriff S; Einspahr H; Kish K; Malley MF; DiMarco JD; Gougoutas JZ; Kadiyala P; Cheney DL; Tejwani RW; Murphy DK; Mcintyre KW; Yang X; Chao S; Leith L; Xiao Z; Mathur A; Chen BC; Wu DR; Traeger SC; McKinnon M; Barrish JC; Robl JA; Iwanowicz EJ; Suchard SJ; Dhar TG
    J Med Chem; 2006 Nov; 49(24):6946-9. PubMed ID: 17125246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).
    Watterson SH; Xiao Z; Dodd DS; Tortolani DR; Vaccaro W; Potin D; Launay M; Stetsko DK; Skala S; Davis PM; Lee D; Yang X; McIntyre KW; Balimane P; Patel K; Yang Z; Marathe P; Kadiyala P; Tebben AJ; Sheriff S; Chang CY; Ziemba T; Zhang H; Chen BC; DelMonte AJ; Aranibar N; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
    J Med Chem; 2010 May; 53(9):3814-30. PubMed ID: 20405922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis.
    Suchard SJ; Stetsko DK; Davis PM; Skala S; Potin D; Launay M; Dhar TG; Barrish JC; Susulic V; Shuster DJ; McIntyre KW; McKinnon M; Salter-Cid L
    J Immunol; 2010 Apr; 184(7):3917-26. PubMed ID: 20190141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite generation via microbial biotransformations with Actinomycetes: rapid screening for active strains and biosynthesis of important human metabolites of two development-stage compounds, 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101) and dasatinib.
    Li W; Josephs JL; Skiles GL; Humphreys WG
    Drug Metab Dispos; 2008 Apr; 36(4):721-30. PubMed ID: 18227141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.
    Gadek TR; Burdick DJ; McDowell RS; Stanley MS; Marsters JC; Paris KJ; Oare DA; Reynolds ME; Ladner C; Zioncheck KA; Lee WP; Gribling P; Dennis MS; Skelton NJ; Tumas DB; Clark KR; Keating SM; Beresini MH; Tilley JW; Presta LG; Bodary SC
    Science; 2002 Feb; 295(5557):1086-9. PubMed ID: 11834839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.
    Weitz-Schmidt G; Welzenbach K; Brinkmann V; Kamata T; Kallen J; Bruns C; Cottens S; Takada Y; Hommel U
    Nat Med; 2001 Jun; 7(6):687-92. PubMed ID: 11385505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.
    Kallen J; Welzenbach K; Ramage P; Geyl D; Kriwacki R; Legge G; Cottens S; Weitz-Schmidt G; Hommel U
    J Mol Biol; 1999 Sep; 292(1):1-9. PubMed ID: 10493852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
    Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
    ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.
    Roehrig S; Straub A; Pohlmann J; Lampe T; Pernerstorfer J; Schlemmer KH; Reinemer P; Perzborn E
    J Med Chem; 2005 Sep; 48(19):5900-8. PubMed ID: 16161994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of I domain and global conformational changes in LFA-1: refinement of small molecule-I domain structure-activity relationships.
    Larson RS; Davis T; Bologa C; Semenuk G; Vijayan S; Li Y; Oprea T; Chigaev A; Buranda T; Wagner CR; Sklar LA
    Biochemistry; 2005 Mar; 44(11):4322-31. PubMed ID: 15766261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.
    Wu JP; Emeigh J; Gao DA; Goldberg DR; Kuzmich D; Miao C; Potocki I; Qian KC; Sorcek RJ; Jeanfavre DD; Kishimoto K; Mainolfi EA; Nabozny G; Peng C; Reilly P; Rothlein R; Sellati RH; Woska JR; Chen S; Gunn JA; O'Brien D; Norris SH; Kelly TA
    J Med Chem; 2004 Oct; 47(22):5356-66. PubMed ID: 15481974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
    Nam K; Maiorov V; Feuston B; Kearsley S
    Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
    Crosignani S; Page P; Missotten M; Colovray V; Cleva C; Arrighi JF; Atherall J; Macritchie J; Martin T; Humbert Y; Gaudet M; Pupowicz D; Maio M; Pittet PA; Golzio L; Giachetti C; Rocha C; Bernardinelli G; Filinchuk Y; Scheer A; Schwarz MK; Chollet A
    J Med Chem; 2008 Apr; 51(7):2227-43. PubMed ID: 18318469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion.
    Yusuf-Makagiansar H; Yakovleva TV; Tejo BA; Jones K; Hu Y; Verkhivker GM; Audus KL; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):237-46. PubMed ID: 17718718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
    Dodd DS; Sheriff S; Chang CJ; Stetsko DK; Phillips LM; Zhang Y; Launay M; Potin D; Vaccaro W; Poss MA; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1908-11. PubMed ID: 17291752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
    Potin D; Launay M; Nicolai E; Fabreguette M; Malabre P; Caussade F; Besse D; Skala S; Stetsko DK; Todderud G; Beno BR; Cheney DL; Chang CJ; Sheriff S; Hollenbaugh DL; Barrish JC; Iwanowicz EJ; Suchard SJ; Dhar TG
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1161-4. PubMed ID: 15686933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of encoded library technology (ELT) to a protein-protein interaction target: discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists.
    Kollmann CS; Bai X; Tsai CH; Yang H; Lind KE; Skinner SR; Zhu Z; Israel DI; Cuozzo JW; Morgan BA; Yuki K; Xie C; Springer TA; Shimaoka M; Evindar G
    Bioorg Med Chem; 2014 Apr; 22(7):2353-65. PubMed ID: 24593905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
    Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.